蚂蚁集团出手，领投L4无人驾驶企业数亿美元融资；新锐AIGC视频生成大模型创企获复星等投资 | 每周十大股权投资

Financing Transactions - Boson Quantum completed a Series A+ financing round, raising hundreds of millions of RMB, with investments from Qif Capital and GF Xinde, focusing on the development and industrialization of domestic optical quantum computers [1] - Tongchuang Purun, a leading manufacturer of high-purity metal materials, secured 1 billion RMB in Pre-IPO financing, with investors including SAIC Group's Shangqi Capital, addressing critical material needs in the semiconductor and display panel industries [1] - Aishi Technology, an AIGC video platform, raised 100 million RMB in Series B+ financing, backed by Fosun Ruijing Capital and Shunxi Fund, focusing on AI video generation technology [2] - Zero Gravity Aircraft Industry, specializing in eVTOL aircraft, completed a Series A+ financing round of 300 million RMB, with investments from Fangguang Capital and Sichuan Industrial Revitalization Fund, aligning with the national "low-altitude economy" strategy [2] - Jiushi Intelligent, a global L4 autonomous driving company, raised hundreds of millions of USD in Series C financing led by Ant Group, focusing on B2B urban freight solutions [3] - Tupu Medical, a leader in high-end ophthalmic medical equipment, completed a strategic financing round with investors including Beijing Guoguan, aiming to break the monopoly of imported brands in the high-end ophthalmic equipment market [3] - Wolant Aviation, engaged in eVTOL development, completed hundreds of millions of RMB in Series B financing, attracting top-tier investment institutions [4] - Revolut, a leading fintech platform, secured a strategic financing round of up to 3 billion USD (approximately 19.5 billion RMB), enhancing its position as Europe's most valuable fintech unicorn [4] - Lila Sciences, an innovative tech company, completed 115 million USD in Series A financing, with investments from General Catalyst and Nvidia, highlighting the potential of AI for science [5] - Trogenix, a UK-based biotech company focused on innovative cancer gene therapies, raised 95 million USD in Series A financing, receiving investments from Eli Lilly and several specialized medical venture funds [5]